← Evidence map

ReviewOncoTargets and therapy2016

Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma.

Maria Banzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27226731